91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Zidovudine API Market Research Report 2025

Global Zidovudine API Market Research Report 2025

Publication ID: 
PB501254502
Publication Date: 
February 5, 2025
Pages: 
89
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

The global market for Zidovudine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Zidovudine(CAS锛�30516-87-1) is a nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents in the therapy and prophylaxis of the human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Zidovudine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zidovudine API.
The Zidovudine API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Zidovudine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zidovudine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical
by Type
Above 98 %
Above 99 %
by Application
Injection
Tablets
Capsules
Others
Production by Region
North America
China
India
Brazil
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zidovudine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Zidovudine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Zidovudine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Zidovudine API Market Overview
1.1 Product Definition
1.2 Zidovudine API by Type
1.2.1 Global Zidovudine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Zidovudine API by Application
1.3.1 Global Zidovudine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Injection
1.3.3 Tablets
1.3.4 Capsules
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Zidovudine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Zidovudine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Zidovudine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Zidovudine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Zidovudine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Zidovudine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Zidovudine API, Industry Ranking, 2023 VS 2024
2.4 Global Zidovudine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Zidovudine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Zidovudine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Zidovudine API, Product Offered and Application
2.8 Global Key Manufacturers of Zidovudine API, Date of Enter into This Industry
2.9 Zidovudine API Market Competitive Situation and Trends
2.9.1 Zidovudine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Zidovudine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Zidovudine API Production by Region
3.1 Global Zidovudine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Zidovudine API Production Value by Region (2020-2031)
3.2.1 Global Zidovudine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Zidovudine API by Region (2026-2031)
3.3 Global Zidovudine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Zidovudine API Production Volume by Region (2020-2031)
3.4.1 Global Zidovudine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Zidovudine API by Region (2026-2031)
3.5 Global Zidovudine API Market Price Analysis by Region (2020-2025)
3.6 Global Zidovudine API Production and Value, Year-over-Year Growth
3.6.1 North America Zidovudine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Zidovudine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 India Zidovudine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Brazil Zidovudine API Production Value Estimates and Forecasts (2020-2031)
4 Zidovudine API Consumption by Region
4.1 Global Zidovudine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Zidovudine API Consumption by Region (2020-2031)
4.2.1 Global Zidovudine API Consumption by Region (2020-2025)
4.2.2 Global Zidovudine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Zidovudine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Zidovudine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Zidovudine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Zidovudine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Zidovudine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Zidovudine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Zidovudine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Zidovudine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Zidovudine API Production by Type (2020-2031)
5.1.1 Global Zidovudine API Production by Type (2020-2025)
5.1.2 Global Zidovudine API Production by Type (2026-2031)
5.1.3 Global Zidovudine API Production Market Share by Type (2020-2031)
5.2 Global Zidovudine API Production Value by Type (2020-2031)
5.2.1 Global Zidovudine API Production Value by Type (2020-2025)
5.2.2 Global Zidovudine API Production Value by Type (2026-2031)
5.2.3 Global Zidovudine API Production Value Market Share by Type (2020-2031)
5.3 Global Zidovudine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Zidovudine API Production by Application (2020-2031)
6.1.1 Global Zidovudine API Production by Application (2020-2025)
6.1.2 Global Zidovudine API Production by Application (2026-2031)
6.1.3 Global Zidovudine API Production Market Share by Application (2020-2031)
6.2 Global Zidovudine API Production Value by Application (2020-2031)
6.2.1 Global Zidovudine API Production Value by Application (2020-2025)
6.2.2 Global Zidovudine API Production Value by Application (2026-2031)
6.2.3 Global Zidovudine API Production Value Market Share by Application (2020-2031)
6.3 Global Zidovudine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Zidovudine API Company Information
7.1.2 Mylan Zidovudine API Product Portfolio
7.1.3 Mylan Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 Hetero Drugs
7.2.1 Hetero Drugs Zidovudine API Company Information
7.2.2 Hetero Drugs Zidovudine API Product Portfolio
7.2.3 Hetero Drugs Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Hetero Drugs Main Business and Markets Served
7.2.5 Hetero Drugs Recent Developments/Updates
7.3 HEC Pharm
7.3.1 HEC Pharm Zidovudine API Company Information
7.3.2 HEC Pharm Zidovudine API Product Portfolio
7.3.3 HEC Pharm Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 HEC Pharm Main Business and Markets Served
7.3.5 HEC Pharm Recent Developments/Updates
7.4 ZHEJIANG LANGHUA PHARMACEUTICAL
7.4.1 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Company Information
7.4.2 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Product Portfolio
7.4.3 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 ZHEJIANG LANGHUA PHARMACEUTICAL Main Business and Markets Served
7.4.5 ZHEJIANG LANGHUA PHARMACEUTICAL Recent Developments/Updates
7.5 Shanghai Shyndec Pharmaceutical
7.5.1 Shanghai Shyndec Pharmaceutical Zidovudine API Company Information
7.5.2 Shanghai Shyndec Pharmaceutical Zidovudine API Product Portfolio
7.5.3 Shanghai Shyndec Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shanghai Shyndec Pharmaceutical Main Business and Markets Served
7.5.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
7.6 Shanghai Desano Bio-Pharmaceutical
7.6.1 Shanghai Desano Bio-Pharmaceutical Zidovudine API Company Information
7.6.2 Shanghai Desano Bio-Pharmaceutical Zidovudine API Product Portfolio
7.6.3 Shanghai Desano Bio-Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Shanghai Desano Bio-Pharmaceutical Main Business and Markets Served
7.6.5 Shanghai Desano Bio-Pharmaceutical Recent Developments/Updates
7.7 Cipla
7.7.1 Cipla Zidovudine API Company Information
7.7.2 Cipla Zidovudine API Product Portfolio
7.7.3 Cipla Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Cipla Main Business and Markets Served
7.7.5 Cipla Recent Developments/Updates
7.8 Nortec Quimica
7.8.1 Nortec Quimica Zidovudine API Company Information
7.8.2 Nortec Quimica Zidovudine API Product Portfolio
7.8.3 Nortec Quimica Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Nortec Quimica Main Business and Markets Served
7.8.5 Nortec Quimica Recent Developments/Updates
7.9 Globe Quimica Ltda
7.9.1 Globe Quimica Ltda Zidovudine API Company Information
7.9.2 Globe Quimica Ltda Zidovudine API Product Portfolio
7.9.3 Globe Quimica Ltda Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Globe Quimica Ltda Main Business and Markets Served
7.9.5 Globe Quimica Ltda Recent Developments/Updates
7.10 Guangzhou Tosun Pharmaceutical
7.10.1 Guangzhou Tosun Pharmaceutical Zidovudine API Company Information
7.10.2 Guangzhou Tosun Pharmaceutical Zidovudine API Product Portfolio
7.10.3 Guangzhou Tosun Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.10.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Zidovudine API Industry Chain Analysis
8.2 Zidovudine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Zidovudine API Production Mode & Process Analysis
8.4 Zidovudine API Sales and Marketing
8.4.1 Zidovudine API Sales Channels
8.4.2 Zidovudine API Distributors
8.5 Zidovudine API Customer Analysis
9 Zidovudine API Market Dynamics
9.1 Zidovudine API Industry Trends
9.2 Zidovudine API Market Drivers
9.3 Zidovudine API Market Challenges
9.4 Zidovudine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned: 

Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-zidovudine-api-market-research-report-2025

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals